Evidence map›Paper›PMID 31422129›Full record

Trial reportJACC. Cardiovascular imaging2020

Augmentation of Tissue Perfusion in Patients With Peripheral Artery Disease Using Microbubble Cavitation.

O'Neil R Mason, Brian P Davidson, Paul Sheeran, Matthew Muller, James M Hodovan, Jonathan Sutton, Jeffry Powers, Jonathan R Lindner

Registry-linked trialOpen access · greenAbstract readClinical Trial
In one paragraph

Trial report in JACC. Cardiovascular imaging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03195556 (Augmentation of Limb Perfusion With Contrast Ultrasound), which is not on this map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03195556 narecruitingnot on this map

Augmentation of Limb Perfusion With Contrast Ultrasound

TypeinterventionalSponsorOregon Health and Science UniversityRan2018 to 2019Enrolled30ConditionsPeripheral Arterial DiseaseArmsUltrasound
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 41 citations in OpenAlex.

  1. Trial
  2. Article
  3. Influence of Microbubble Properties and Carrier Frequency on Ultrasound Cavitation-Induced Flow Augmentation.Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography · 2026
    Article
  4. Review
  5. Article
  6. Delivery of Cavitation Therapy With a Modified Clinical Scanner: In Vitro Evaluation.IEEE transactions on ultrasonics, ferroelectrics, and frequency control · 2025
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Influence of Atherosclerotic Risk Factors on the Effectiveness of Therapeutic Ultrasound Cavitation for Flow Augmentation.Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography · 2024
    Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Advances in Ultrasound Therapeutics.Current cardiology reports · 2021
    Review
  19. Article
  20. Augmentation of Tissue Perfusion with Contrast Ultrasound: Influence of Three-Dimensional Beam Geometry and Conducted Vasodilation.Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

O'Neil R MasonKnight Cardiovascular Institute, Portland, Oregon.
Brian P DavidsonKnight Cardiovascular Institute, Portland, Oregon.
Paul SheeranPhilips Ultrasound, Bothell, Washington; and Philips Research, Cambridge, Massachusetts.
Matthew MullerKnight Cardiovascular Institute, Portland, Oregon.
James M HodovanKnight Cardiovascular Institute, Portland, Oregon.
Jonathan SuttonOregon National Primate Research Center, Oregon Health & Science University, Portland, Oregon.
Jeffry PowersPhilips Ultrasound, Bothell, Washington; and Philips Research, Cambridge, Massachusetts.
Jonathan R LindnerKnight Cardiovascular Institute, Portland, Oregon; Oregon National Primate Research Center, Oregon Health & Science University, Portland, Oregon. Electronic address: lindnerj@ohsu.edu.
Cardiovascular Institute of the South · USOregon National Primate Research Center · USPhilips (Finland) · FI

Funding

Upgrade of confocal microscopy at the Oregon National Primate Research CenterP51OD011092 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Bonnie J. Nagel · 2012 to 2026
$203.9M
Targeted CEU Imaging of Atherosclerosis and AngiogenesisR01HL078610 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI LINDNER, JONATHAN R · 2004 to 2022
$6.8M
Augmentation of Tissue Perfusion with Ultrasound-mediated CavitationR01HL130046 · NHLBI · UNIVERSITY OF VIRGINIA · PI LINDNER, JONATHAN R · 2016 to 2023
$5.5M
Training in Translational Science and Cardiovascular MedicineT32HL094294 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI ALKAYED, NABIL J · 2009 to 2018
$3.5M
NHLBI NIH HHS R01 HL078610NHLBI NIH HHS R01 HL130046NHLBI NIH HHS T32 HL094294NIH HHS P51 OD011092
6 · The paper itself

Abstract

objectivesThe authors investigated ideal acoustic conditions on a clinical scanner custom-programmed for ultrasound (US) cavitation-mediated flow augmentation in preclinical models. We then applied these conditions in a first-in-human study to test the hypothesis that contrast US can increase limb perfusion in normal subjects and patients with peripheral artery disease (PAD).

backgroundUS-induced cavitation of microbubble contrast agents augments tissue perfusion by convective shear and secondary purinergic signaling that mediates release of endogenous vasodilators.

methodsIn mice, unilateral exposure of the proximal hindlimb to therapeutic US (1.3 MHz, mechanical index 1.3) was performed for 10 min after intravenous injection of lipid microbubbles. US varied according to line density (17, 37, 65 lines) and pulse duration. Microvascular perfusion was evaluated by US perfusion imaging, and in vivo adenosine triphosphate (ATP) release was assessed using in vivo optical imaging. Optimal parameters were then used in healthy volunteers and patients with PAD where calf US alone or in combination with intravenous microbubble contrast infusion was performed for 10 min.

resultsIn mice, flow was augmented in the US-exposed limb for all acoustic conditions. Only at the lowest line density was there a stepwise increase in perfusion for longer (40-cycle) versus shorter (5-cycle) pulse duration. For higher line densities, blood flow consistently increased by 3-fold to 4-fold in the US-exposed limb irrespective of pulse duration. High line density and long pulse duration resulted in the greatest release of ATP in the cavitation zone. Application of these optimized conditions in humans together with intravenous contrast increased calf muscle blood flow by >2-fold in both healthy subjects and patients with PAD, whereas US alone had no effect.

conclusionsUS of microbubbles when using optimized acoustic environments can increase perfusion in limb skeletal muscle, raising the possibility of a therapy for patients with PAD. (Augmentation of Limb Perfusion With Contrast Ultrasound; NCT03195556).

Indexed as

Ultrasonic TherapyAgedAnimalsBlood Flow VelocityContrast MediaDisease Models, AnimalFemaleHindlimbHumansInjections, IntravenousLegMaleMiceMice, Inbred C57BLMicrobubblesMiddle AgedContrast Mediacavitationmicrocirculationmuscle perfusionperipheral artery diseaseultrasound

Identifiers

PMID31422129
PMCPMC7018586
OpenAlexW2968924344

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.